Axios

WASHINGTON — High maternal mortality in the U.S. is preventable, according to advocates, physicians, policy leaders and executives at an Axios Future of Health event on May 13.

Why it matters: The United States has the highest maternal mortality rate among wealthy countries, despite most pregnancy-related deaths being preventable.

Axios' Maya Goldman and Caitlin Owens moderated the Expert Voices roundtable, which was sponsored by Heartland Forward.

By the numbers: 649 women died of maternal causes in the U.S. in 2024, according to the Centers for Disease Control and Prevention. Most of these deaths are considered avoidable and the actual numbers may be undercounted.

• One-third of U.S. counties lack hospitals, obstetricians or birth centers, said Stephanie Ogorzalek, Planned Parenthood Federation of America vice president of research and policy.
• Black women are up to three times more likely to die from pregnancy-related causes, she added.

Case in point: 4Kira4Moms founder Charles Johnson's wife, Kira, died due to preventable internal bleeding shortly after she delivered their son via C-section in 2016.

• "One of the things we're focused on is developing programs, tools, and giving fathers everything they need to show up as that rightful advocate and support person," he said.

What they're saying: "It's actually not rocket science," Centene chief health officer Alice Chen said. "We don't need a lot more studies."

• What families need are doulas, midwives and continuous postpartum Medicaid eligibility, she added.
• Paid leave and eradicating maternal mortality are "inextricably linked," Bobbie director of impact and policy Michele Lampach said.
• "Giving everyone remote blood pressure monitors is incredibly effective," said Ivirma Global chief transformation officer Elena Mendez-Escobar.

Stunning stat: Preeclampsia, the condition of dangerously high blood pressure associated with pregnancy, accounts for "11%–14% of maternal mortality globally and is the second most frequent direct obstetrical cause of death," according to a 2025 study.

State of play: White House officials hope to build on a four-year pilot program involving over 200 hospitals that found a "41.5% reduction in maternal mortality," Health and Human Services chief counselor Chris Klomp said.

• "We had funds. We've done it. We want to do more of it, because that's an extraordinary result."

What's next: Advocates need to craft and spread a compelling narrative, BirthFund founder Elaine Welteroth said.

• "We don't want to just keep telling Black women or other women that you're going to die in birth," she said. There is "a solution and a pathway to safer, beautiful, joyful, sacred birth."
• "Data informs people, but people move people," Johnson said.

Content from the sponsor's remarks:

Olivia Walton, founder of the maternal and child health center for policy and practice at Heartland Forward, and founder and CEO at Ingeborg, said that her bipartisan "Healthy Moms, Healthy Babies America" initiative is part of a five-year sprint to cut the U.S. maternal mortality rate in half.

• "The stakes are too high and the solutions are too clear not to get arm-in-arm and work on this together," she said.
• "We know what works. We know the time is now," Heartland Forward president Angie Cooper added.

WASHINGTON — Health care costs and how to address them dominated the conversations at Axios' second annual Future of Health Summit this week as the country approaches the 2026 midterm elections.

Why it matters: Prices are top of mind for executives, policymakers and industry leaders as health care bills continue to strain Americans' finances.

• The event was sponsored by Covista, Genentech, Heartland Forward and UnitedHealth Group.

By the numbers: A KFF poll released this week revealed more than half of voters said health care costs would influence their votes.

• 75% of respondents in the summit's live audience poll said the one thing they'd change about the health care system would be costs.

Catch up quick: Here are our top five takeaways from the conversations …

1. Pharmaceutical leaders say high drug costs are being driven by complex legislation, FDA volatility and unfair international policy.

• "340B [the federal discount drug program] is a classic example of legislation that was well-intentioned, that has gotten out of control," Bristol Myers Squibb board chair and CEO Chris Boerner said.
• "We need predictability and, by extension, stability," he added.
• Other countries not paying their fair share of prescription medicine "amounts to about a 26% tax on U.S. consumers," PhRMA president and CEO Stephen J. Ubl said.

2. Fraud is top of mind, as leaders point to wasteful and inaccurate spending.

• Caryn Seidman Becker, chair and CEO of facial recognition technology CLEAR, says identify verification can reduce instances of fraud and save the government money.
• "If you look at a GAO report from December … there were 125 [policies] associated with one Social Security number," she said.
• "We are putting a national moratorium on all new hospices," Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, told Axios' Caitlin Owens, citing concerns in New York and California.

3. The health care system itself isn't designed for our modern reality, Sesame co-founder and CEO David Goldhill said.

• "We built a health care system based on what health care looked like in the mid-20th century," and now it "has more people managing the payment system than practicing physicians," he said.
• The company hopes to alleviate barriers between patients and providers by eliminating the insurance go-between entirely.

4. Sen. Peter Welch (D-Vt.) said he would support a proposal from President Trump to reduce health care costs for American families.

• He would "not only vote for it, I would work actively and aggressively to make it happen."
• Reality check: "The president hasn't introduced any legislation."

5. Oz announced a coalition to address prior authorization delays.

• "All of a sudden, the long arm of insurance comes in there, even though you're paying your fees [and] your premiums," he said. It is "probably the single most disliked part of the health care system."
• "The payers, the insurance companies, have been playing ball. Guess who's not been playing ball until today? The providers."

What's next: Republicans must decide whether they want to wade into controversial waters between now and the November election.

Content from the sponsors' segments:

In View From the Top conversations, Covista medical and veterinary president Scott Liles shared that 80% of health care professionals who responded to a joint survey with Gallup reported not having enough of what they need, "including colleagues on the floor."

• The report also found that 92% of health care executives are struggling to hire physician specialists.

Olivia Walton, founder of the maternal and child health center for policy and practice at Heartland Forward, and founder and CEO at Ingeborg, said solutions to the maternal mortality crisis aren't unaffordable.

• "America spends on average $19,000 per birth," Walton said. "You can actually make birth safer while spending less money on it."
• Maternal mortality "is a systemic issue, and it is going to require systemic interventions," said Elaine Welteroth, founder of BirthFund, author of "More Than Enough" and former Teen Vogue editor-in-chief.

Jon Mahrt, CEO of Optum Rx and chief growth officer of Optum, said the company is focused on addressing costs and transparency.

• "The pharmacy care ecosystem was designed for a simpler time," he said. "Patients crave that simplicity, and the opacity of the system undermines the confidence in that system today."
• "Consumers want direct-to-consumer cash price. … We've built and are launching the Optum Price pharmacy to do just that."

Go deeper: Watch the full conversations on YouTube.

College-educated fathers are spending less time doing paid work and more time doing things like child care and chores at home, according to a new analysis of Census data.

Why it matters: Millennial and Gen X men are more involved fathers than previous generations, a pattern that appears to have accelerated in the post-pandemic period.

The exceptionally high U.S. maternal mortality rate may be a grim topic, but it's also one of health care's solvable problems that can rally widespread bipartisan support.

Why it matters: While health policy is notorious for creating winners and losers, making a dent in maternal mortality stands out for its lack of downsides.

• "This is a priority. I'm here. Others are here. We're paying attention," Health and Human Services chief counselor Chris Klomp, who attended a recent Axios-sponsored lunch on the subject, told attendees.
• And the upfront costs — perhaps the largest barrier to action — could be recouped through reduced future health care spending and higher economic output.
• "There is a positive dollar [return on investment] to making these investments," he added. "What is the cheapest care? It's the care you never needed to render in the first place," he added.

By the numbers: As of December, the Centers for Disease Control and Prevention estimates the maternal mortality rate at 16.6 deaths per 100,000 live births. In 2024, 649 women died during pregnancy or within 42 days of the pregnancy ending.

• More than 80% of those deaths are preventable, the agency said.
• Top causes of death include severe bleeding, infection or sepsis, and cardiovascular conditions, according to the Commonwealth Fund.

Where it stands: Heartland Forward's Healthy Moms, Healthy Babies America launched its campaign this week to cut the rate in half over the next five years. (Heartland Forward sponsored the Axios lunch, though it had nothing to do with me writing about this.)

• It announced a partnership with HHS that will take an evidence-based approach to the issue, including by expanding a federal perinatal improvement collaborative.
• HHS also rolled out Moms.gov, an informational site that attempts to connect new and expecting mothers to resources. The website drew controversy from some corners for its anti-abortion ties.

Details: The Perinatal Improvement Collaborative is a network of more than 220 hospitals and health care teams that are trying to improve maternal and infant health and measure the outcomes.

• In its first four years, it saw a 41.5% reduction in mortality, Klomp said, and severe neonatal complications were reduced by nearly 60%.
• "You want to pay for a program, there's your answer right there. It's paid for because those are really expensive cases," he said.

Yes, but: Reducing maternal deaths is one thing, but truly eliminating the preventable ones requires solving some of health care's thorniest systemic problems.

• Expanding access to care and narrowing maternity deserts tie into much bigger issues around insurance coverage, payment policy, workforce issues and the future of rural health care.
• And addressing those issues is where things can get political, fast.

Plus, some experts argue that the Trump administration's actions have actually undercut its stated commitment to reducing maternal mortality.

• "Cutting maternal mortality in half in five years won't happen if the policy prescriptions are to expand narrowly focused pilot programs while cutting federal funding for Medicaid and cancelling research, grants and programs in the name of ending DEI," said Jennifer Klein, professor of professional practice at Columbia University and chair of the Clinton Policy Institute.

My thought bubble: Maternal mortality is one of those things everyone agrees is bad and should be worked on — and yet U.S. death rates are still high relative to other nations.

• Caring about the issue is one thing, and acting on it is another. But that's why the Perinatal Improvement Collaborative is interesting — it appears to be a genuinely successful effort that could be replicable on a larger scale.
• Its reduction in the mortality rate makes Heartland Forward's goal of reducing deaths by half in the next five years sound less audacious.

The story has been updated with additional reporting.

Two high-profile doctors are urging policymakers to support autonomous vehicle deployment, arguing the technology is already saving lives and should be a public health imperative.

Why it matters: It adds a public health voice to a broader policy push by the AV industry as state legislation stalls and debate over long-delayed federal regulations heats up in Congress.

The federal government's lagging response to the hantavirus outbreak aboard a cruise ship is fueling concerns about the government's preparedness for a more widespread infectious disease emergency.

Why it matters: Public health experts say the response underscored vulnerabilities tied to the U.S. withdrawal from the World Health Organization, as well as layoffs and leadership turnover at federal agencies like the Centers for Disease Control and Prevention.

Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy.

• But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure.

Why it matters: There's lots of uncertainty around how the Senate will find the bandwidth to confirm another FDA commissioner while it considers President Trump's nominees for Centers for Disease Control and Prevention director and surgeon general.

Anyone who's been on a dating app knows the weary disclaimer: "Not looking for a pen pal." Since the pandemic, and as Gen Z has come of age, people looking for love have soured entirely on swiping.

Why it matters: The push for in-person connection shows up in research data, product launches, extensive coverage of the loneliness epidemic, and Gen Z's app aversion.

But approaching and connecting with strangers in real life is a different skill — and for many daters, a rusty one.

Food and Drug Administration Commissioner Marty Makary is stepping down after a turbulent 13-month term marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

• Kyle Diamantas, the agency's deputy commissioner for food, will serve as acting commissioner, President Trump posted on Truth Social.

Weight-loss drugs are reshaping bridal retail — and David's Bridal is responding to brides' growing "fit anxiety" with a new guarantee.

Why it matters: GLP-1 medications are changing how consumers shop for wedding attire, forcing retailers to adapt to rapidly shifting body sizes, compressed shopping timelines and a surge in last-minute alterations.